Retrospective Study
Copyright ©The Author(s) 2020.
World J Clin Oncol. Nov 24, 2020; 11(11): 918-934
Published online Nov 24, 2020. doi: 10.5306/wjco.v11.i11.918
Figure 2
Figure 2 Cross-validation score change for selecting optimal number of features. LN: Lymph node; SEER: Surveillance, Epidemiology, and End Results; AJCC: American Joint Committee on Cancer; CS: Coding system; ICD-O-3: International Classification of Diseases for Oncology, 3rd ed; WHO: World Health Organization.